KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 121 filers reported holding KALA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 26 | -99.9% | 0.00% | – |
| Q3 2021 | $49,000 | -51.0% | 18,454 | -3.3% | 0.00% | – |
| Q2 2021 | $100,000 | -21.3% | 19,081 | +1.0% | 0.00% | – |
| Q1 2021 | $127,000 | -52.4% | 18,885 | -52.1% | 0.00% | – |
| Q4 2020 | $267,000 | +45.9% | 39,407 | +61.4% | 0.00% | – |
| Q3 2020 | $183,000 | -16.1% | 24,409 | +17.6% | 0.00% | – |
| Q2 2020 | $218,000 | – | 20,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,704,849 | $9,036,000 | 6.19% |
| RA Capital Management | 10,874,613 | $57,635,000 | 0.92% |
| Mesirow Financial Investment Management, Inc. | 42,104 | $223,000 | 0.57% |
| ACT CAPITAL MANAGEMENT, LLC | 190,000 | $1,007,000 | 0.52% |
| Samsara BioCapital, LLC | 601,162 | $3,186,000 | 0.39% |
| Orbimed Advisors | 5,465,030 | $28,965,000 | 0.29% |
| ALGERT GLOBAL LLC | 72,490 | $384,000 | 0.13% |
| Knights of Columbus Asset Advisors LLC | 236,257 | $1,252,000 | 0.12% |
| Bridgefront Capital, LLC | 47,569 | $252,000 | 0.10% |
| Matisse Capital | 56,100 | $297,000 | 0.09% |